Skip to content

Author

Hyeon-Cheol Gwon

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Association of Shock-to-Balloon Time With Outcomes in Acute Myocardial Infarction With Cardiogenic Shock Requiring VA-ECMO.

The optimal timing of percutaneous coronary intervention (PCI) in patients with acute myocardial infarction complicated by cardiogenic shock (AMI-CS) who are supported with venoarterial extracorporeal membrane oxygenation (VA-ECMO) remains uncertain. We aimed to evaluate the prognostic impact of shock-to-balloon time (STB) in AMI-CS patients supported with VA-ECMO before revascularization. This study included patient-pooled data from CS-dedicated registries, including the SMART-RESCUE and the SMC-ECMO. A total of 256 patients were included. Patients were stratified according to STB (<120 min, n = 140; ≥120 min, n = 116). Among the study population, all-cause mortality was significantly higher in the ≥120 minutes group compared with the <120 minutes group (65.2% vs. 44.6%; adjusted hazard ratio [HR]: 1.59, 95% confidence interval [CI]: 1.03-2.45, p = 0.037). This association was significant in the ST-segment elevation myocardial infarction (STEMI) subgroup (adjusted HR: 2.22, 95% CI: 1.26-3.93), and in patients with earlier (<60 min) VA-ECMO initiation (adjusted HR: 2.50, 95% CI: 1.42-4.38), whereas in the non-ST-segment elevation myocardial infarction (NSTEMI) subgroup a directionally consistent but nonsignificant trend was observed, without significant interaction (p-for-interaction = 0.164). In AMI-CS patients who underwent VA-ECMO, a prolonged STB was associated with higher all-cause mortality, with a consistent but exploratory trend in NSTEMI. These findings support STB as a prognostic marker and warrant prospective evaluation of coordinated ECMO-revascularization pathways.

Onyou Kim, Ji Hyun Cha, Sang Yoon Lee et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.